Sameeh M. Salama
Vice President
Business Development
FEDORA Pharmaceuticals
Canada
Biography
Dr. Sameeh M. Salama is the vice president of business development at Fedora Pharmaceuticals Inc. He currently also holds the title of vice president of business development at Brass Dome Ventures Ltd., a management and business consultancy. Earlier in his career, Dr. Salama was vice president of the contract-research organization, NAEJA Pharmaceuticals Inc. In this role, he was actively involved in over a dozen licensing and partnership agreements, including the licensing of NAEJA’s Beta-lactamase inhibitors to Fedora Pharmaceuticals Inc. and later the licensing of the same assets to F. Hoffman La Roche in a record-setting US$750 million license deal. Dr. Salama’s tenure at NAEJA involved securing dozens of contract research agreements, strategic planning, and establishing a wide network of contacts within the industry worldwide. Prior to joining NAEJA, Dr. Salama was a director of microbiology at SynPhar laboratories Inc. Dr. Salama received his Ph.D. in medical microbiology in 1990 from the University of Salford, U.K. and spent four years as a post-doctoral fellow with Dr. Diane E. Taylor at the University of Alberta in Edmonton, Canada. He has published over 30 peer-reviewed articles and is a co-inventor in several patents.
Research Interest
Business Development, Marketing and Accounting
